Cargando…
Interstitial cystitis intravesical therapy
Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladd...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522791/ https://www.ncbi.nlm.nih.gov/pubmed/28791236 http://dx.doi.org/10.21037/tau.2017.06.18 |
_version_ | 1783252218412007424 |
---|---|
author | Ha, Tanya Xu, Jie Hua |
author_facet | Ha, Tanya Xu, Jie Hua |
author_sort | Ha, Tanya |
collection | PubMed |
description | Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladder urothelium. This defect allows an influx of ions, particularly potassium, which initiates an inflammatory reaction in the bladder wall, which incites the symptoms described above. Treatment initially involves behavioural and oral medication, with second line being intravesical instillation therapy. Treatment strategies focus on restoring lower urinary tract epithelial function, inhibiting neural activation, controlling allergies and relieving symptoms. In this review, current intravesical therapy will be discussed, as well as what lies on the horizon for intravesical therapy in IC. |
format | Online Article Text |
id | pubmed-5522791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-55227912017-08-08 Interstitial cystitis intravesical therapy Ha, Tanya Xu, Jie Hua Transl Androl Urol Review Article Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladder urothelium. This defect allows an influx of ions, particularly potassium, which initiates an inflammatory reaction in the bladder wall, which incites the symptoms described above. Treatment initially involves behavioural and oral medication, with second line being intravesical instillation therapy. Treatment strategies focus on restoring lower urinary tract epithelial function, inhibiting neural activation, controlling allergies and relieving symptoms. In this review, current intravesical therapy will be discussed, as well as what lies on the horizon for intravesical therapy in IC. AME Publishing Company 2017-07 /pmc/articles/PMC5522791/ /pubmed/28791236 http://dx.doi.org/10.21037/tau.2017.06.18 Text en 2017 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Review Article Ha, Tanya Xu, Jie Hua Interstitial cystitis intravesical therapy |
title | Interstitial cystitis intravesical therapy |
title_full | Interstitial cystitis intravesical therapy |
title_fullStr | Interstitial cystitis intravesical therapy |
title_full_unstemmed | Interstitial cystitis intravesical therapy |
title_short | Interstitial cystitis intravesical therapy |
title_sort | interstitial cystitis intravesical therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522791/ https://www.ncbi.nlm.nih.gov/pubmed/28791236 http://dx.doi.org/10.21037/tau.2017.06.18 |
work_keys_str_mv | AT hatanya interstitialcystitisintravesicaltherapy AT xujiehua interstitialcystitisintravesicaltherapy |